Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
11.03
-0.09 (-0.85%)
At close: Oct 24, 2025, 4:00 PM EDT
11.05
+0.03 (0.23%)
After-hours: Oct 24, 2025, 4:00 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $309.16 million as of October 24, 2025. Its market cap has decreased by -30.00% in one year.
Market Cap
309.16M
Enterprise Value
136.48M
1-Year Change
-30.00%
Ranking
Category
Stock Price
$11.03
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has decreased from $402.09M to $309.16M, a decrease of -23.11%. That is a compound annual growth rate of -15.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 311.83M | -17.43% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.08B |
| Johnson & Johnson | 462.74B |
| AbbVie | 403.22B |
| UnitedHealth Group | 326.45B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 236.86B |
| Abbott Laboratories | 219.89B |